0 NASDAQ Companies - December 26, 2023Entera Bio Announces Closing of Private Placement – Extends Cash Runway into 2025JERUSALEM, Dec. 26, 2023 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the […]Read More
0 NASDAQ Companies - December 26, 2023WiMi Applied Bitcoin Algorithm DHT Technology to Build Decentralized File Storage and Sharing SystemBeijing, Dec. 26, 2023 (GLOBE NEWSWIRE) — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global […]Read More
0 NASDAQ Companies - December 26, 2023Inspired Announces CFO TransitionNEW YORK, Dec. 26, 2023 (GLOBE NEWSWIRE) — Inspired Entertainment, Inc. (“Inspired” or the “Company”) (NASDAQ: INSE), a leading B2B […]Read More
0 NASDAQ Companies - December 26, 2023Zymeworks Announces $50 Million Private Placement to EcoR1 CapitalVANCOUVER, British Columbia, Dec. 26, 2023 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biopharmaceutical company developing novel, multifunctional […]Read More
0 NASDAQ Companies - December 26, 2023Daré Bioscience Secures $12 million in Royalty-backed Investment StructureSAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today […]Read More
0 NASDAQ Companies - December 26, 2023Bionano Announces Publication of Largest Prospective Prenatal Study Comparing OGM to Chromosomal Microarray Analysis and KaryotypingKey findings from prospective evaluation of 200 prenatal samples: Optical genome mapping (OGM) detected pathogenic structural variants (SVs) in 20.5% […]Read More
0 NASDAQ Companies - December 26, 2023electroCore Expands Intellectual Property PortfolioROCKAWAY, N.J., Dec. 26, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today […]Read More
0 NASDAQ Companies - December 26, 202360 Degrees Pharma Announces IRB Approval of Phase IIA Study to Evaluate Tafenoquine for Babesiosis, an Emerging Tick-Borne Disease; Type C Meeting Re-Scheduled by FDA to January 17, 2024 Investigational Review Board (IRB) approval has been granted for 60 Degrees Pharma’s double-blind, placebo-controlled study to investigate tafenoquine for treatment […]Read More
0 TSX News - December 26, 2023Fairfax Successfully Completes Acquisition of Additional 46.32% Interest in Gulf Insurance Group From KIPCOTORONTO, Dec. 26, 2023 (GLOBE NEWSWIRE) — Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces the successful completion […]Read More
0 NASDAQ Companies - December 26, 2023Shenzhen Bao’an District and EHang Announce Launch of UAM Operation Demonstration Center at OH BayGUANGZHOU, China, Dec. 26, 2023 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading […]Read More